According to Zhou B et al., miR-655 could inhibit the expression of TGF-BR-1 and TGF-BR-2, thus reducing the invasiveness of PC and improving the feasibility of operation (Zhou et al., 2018). This evidence concerns the gene TGFBR2 and pachyonychia congenita.